A detailed history of Mesirow Institutional Investment Management, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Mesirow Institutional Investment Management, Inc. holds 13,676 shares of CRL stock, worth $2.5 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
13,676
Holding current value
$2.5 Million
% of portfolio
0.26%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$206.39 - $268.73 $2.82 Million - $3.68 Million
13,676 New
13,676 $2.83 Million
Q4 2022

Feb 06, 2023

BUY
$197.11 - $250.07 $454,338 - $576,411
2,305 Added 19.81%
13,940 $3.04 Million
Q3 2022

Nov 08, 2022

BUY
$182.44 - $250.54 $2.12 Million - $2.92 Million
11,635 New
11,635 $2.29 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.28B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Mesirow Institutional Investment Management, Inc. Portfolio

Follow Mesirow Institutional Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Institutional Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Institutional Investment Management, Inc. with notifications on news.